News & Media

Investor webinar 5 September 2017

1, September, 2017

Posted In: Featured, In the media, Videos, Blog

Admedus Limited (ASX: AHZ) held an investor webinar on 5 September, 2017 to discuss the results of the Company’s Preliminary Final Report (Appendix 4E) for the year ended 30 June 2017.  Admedus CEO Wayne Paterson will provide a review of the Company’s year-end performance as well as operational and business highlights.

> Read more

Admedus announces exclusive supply agreement with 4C Medical

Admedus announces exclusive supply agreement with 4C Medical

31, August, 2017

Posted In: In the media, Blog

Admedus Limited is pleased to announce that it has entered an exclusive supply agreement with 4C Medical Technologies, Inc. (4C Medical), a Minnesota-based developer of minimally invasive therapies for structural heart disease. Read more here.

> Read more

Admedus beats revenue forecasts for financial year 2017

31, August, 2017

Posted In: Featured, In the media

Admedus has delivered a full year sales increase of 58% to $22.3 million for financial year 2017, compared to the previous financial year. Read more here.

> Read more

Sponsorship supports kids with heart disease

15, August, 2017

Posted In: Featured, In the media

Admedus Ltd is proud to announce a six-month $20k sponsorship of the HeartKids Education Program which provides vital resources for families of children living with congenital/childhood heart disease. In Australia, congenital/childhood heart disease is the leading cause of death for children under a year old and nearly three thousand babies are born with a heart […]

> Read more

Admedus attracts keen interest from surgeons at symposium

11, July, 2017

Posted In: Featured, Blog

Professor Leon Neethling recently attended the 53rd Annual Meeting of the Japanese Society of Paediatric Cardiology and Cardiac Surgery, in Hamamatsu, where he presented at a lunch symposium to more than 180 congenital surgeons from Japan, Vietnam, Philippines, Malaysia, Taiwan and Korea about our ADAPT products as part of the 13th Japan-China-Korea Paediatric Heart Forum.

> Read more

Admedus Ltd readies commercial CardioCel® 3D launch

11, July, 2017

Posted In: Featured, In the media

Proactive Investors takes a look at our plans for CardioCel 3D. Read their latest article here.

> Read more

Admedus CEO Wayne Paterson interview with Proactive Investors

4, July, 2017

Posted In: In the media, Videos

Our CEO Wayne Paterson recently shared his thoughts and vision for Admedus in this interview with Proactive Investors. Watch it now.

> Read more

How to regenerate a regenerative company: CEO talks to MassDevice

4, July, 2017

Posted In: Featured, In the media

Our CEO Wayne Paterson was recently interviewed by MassDevice about the progress Admedus is making. Read the story here.  

> Read more

Admedus welcomes new Chief Operating Officer

9, June, 2017

Posted In: Blog

Admedus welcomes David St. Denis as our new Chief Operating Officer. Read the full Company announcement here.

> Read more

Admedus HSV 2 Phase IIa Results – May 2017

8, May, 2017

Posted In: Videos, Uncategorized

> Watch the video